+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Combigan"

Antiglaucoma Drugs Market Report 2025 - Product Thumbnail Image

Antiglaucoma Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Ocular Hypertension Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Ocular Hypertension Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
From
From
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Combigan is a brand name for a combination of two drugs, brimonidine and timolol, used to treat glaucoma and other optical disorders. It is a topical ophthalmic solution that is applied directly to the eye. The drug works by reducing the pressure in the eye, which can help prevent further damage to the optic nerve. It is often prescribed in combination with other medications to treat glaucoma and other optical disorders. The Combigan market is a competitive one, with several companies offering similar products. Some of the major players in the market include Allergan, Bausch + Lomb, Merck, and Pfizer. Other companies such as Novartis, Sun Pharma, and Santen Pharmaceuticals also offer products in this market. Show Less Read more